Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology

Masahide Harada1, Stanley Nattel2

  • 1Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake 4701192, Japan.

Insights

Inflammation and fibrosis drive atrial fibrillation by promoting cardiac remodeling and conduction issues. Targeting these processes may offer new therapeutic strategies for atrial fibrillation.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Fibrosis Research

Background:

  • Atrial fibrillation (AF) pathophysiology involves inflammation and fibrosis.
  • Atrial fibrosis disrupts normal heart rhythm by causing conduction disturbances.
  • Systemic inflammation activates cardiac fibroblasts, leading to fibrosis.

Purpose of the Study:

  • To review current knowledge on inflammation and fibrosis in atrial fibrillation.
  • To highlight the interplay between inflammation and fibrosis in AF progression.
  • To discuss the potential of targeting inflammation and fibrosis as therapeutic strategies for AF.

Main Methods:

  • Literature review of existing research on atrial fibrillation, inflammation, and fibrosis.
  • Analysis of the mechanisms linking inflammatory mediators to cardiac fibroblast activation.
  • Synthesis of data on the role of fibrosis in atrial remodeling and AF maintenance.

Main Results:

  • Inflammation and fibrosis are key components in the pathophysiology of atrial fibrillation.
  • A complex interplay exists between inflammation and fibrosis, creating a cycle of atrial remodeling.
  • This cycle contributes to the maintenance of atrial fibrillation and increases thrombogenicity.

Conclusions:

  • Inflammation and fibrosis are critical targets for managing atrial fibrillation.
  • Understanding the interplay between these factors is crucial for developing effective therapies.
  • Targeting inflammation and fibrosis holds promise for treating atrial fibrillation and reducing associated risks.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
186
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
162
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
121
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
366
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K